Christopher Betrus, DPM
Foot & Ankle Surgery · Mt Prospect, ILNPI 1477086080
Payments from drug & device makers
Across 186 payments — averaging $74.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Arthrex$4K
- Gentleman Orthopedic Solutions$2K
- Smith+Nephew$667
- Mid-atlantic Surgical Systems, LLC$573
- Kerecis Limited$401
- plus $2K from 31 others
What the payments were for
- Travel & lodging$3,34124%
- Food & beverage$6,14044%
- Education$4,34931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 49 | $4,129 |
| Arthrex | 21 | $3,765 |
| Gentleman Orthopedic Solutions | 6 | $1,900 |
| Smith+Nephew | 28 | $667 |
| Mid-atlantic Surgical Systems, LLC | 5 | $573 |
| Kerecis Limited | 4 | $401 |
| Medical Device Business Services, Inc. | 1 | $320 |
| Orthofix Medical, Inc. | 4 | $185 |
| Medline Industries LP | 2 | $183 |
| Organogenesis Inc. | 3 | $162 |
| Kowa Pharmaceuticals America, Inc. | 7 | $130 |
| Bioventus LLC | 5 | $128 |
| Paratek Pharmaceuticals, Inc. | 7 | $126 |
| Treace Medical Concepts, Inc. | 5 | $115 |
| Acell, Inc. | 1 | $109 |
| Amgen(2 entities) | 5 | $93 |
| Ossio Inc | 1 | $78 |
| Averitas Pharma Inc. | 3 | $78 |
| Nevro Corp. | 4 | $73 |
| Bone Support Inc. | 2 | $71 |
| Pacira Pharmaceuticals Incorporated | 3 | $70 |
| Crossroads Extremity Systems, LLC | 1 | $61 |
| Zimmer Biomet | 3 | $57 |
| Triad Life Sciences Inc. | 2 | $50 |
| Paragon 28, Inc. | 1 | $49 |
| AbbVie | 1 | $28 |
| Solventum Corporation | 1 | $27 |
| Mimedx Group, Inc. | 1 | $26 |
| Globus Medical | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $25 |
| Advanced Oxygen Therapy Inc. | 2 | $24 |
| Stimlabs LLC | 1 | $21 |
| Novastep Inc. | 1 | $19 |
| Reprise Biomedical, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$1,333
- INBONE$753
- SALVATION$340
- VARIAX$276
- Kerecis Omega3 Wound$270
- INFINITY ADAPTIS$174
- AUGMENT INJECTABLE$167
- STAR$151
- Kerecis Omega3 Surgibind$143
- Kerecis Omega3 GraftGuide$143
- Kerecis Omega3 SurgiClose$143
- GRAFIX PL$142
- TrueLok$117
- TL-HEX TRUELOK HEXAPOD SYSTEM$117
- PROPHECY$103
- PURAPLY WOUND MATRIX$103
- Apligraf$103
- Affinity$103
How this compares
$13,830 in reported general payments places this provider in the 85th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $4,958 |
| Diclofenac Sodium | 67 | $801 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 92 | $756 |
| Gabapentin | 35 | $216 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $153 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $143 |
| Ondansetron Hcl | 51 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $667 | $4,95813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 555 foot & ankle surgery providers in Illinois.
Other foot & ankle surgery in Mt Prospect
- Douglas PacaccioRockford$4.3M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.4M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$586K
- Brian BurgessNaperville$496K
- Kyle PearsonMorris$208K
- Stephanie OexemanChicago$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.